FDA inspection
Suzhou Union Biopharm Co., Ltd.: FDA inspection ending Jun 24, 2025
FDA inspection 1274885 · Voluntary Action Indicated (VAI) · Suzhou
Key facts
| Inspection ID | 1274885 |
|---|---|
| Firm | Suzhou Union Biopharm Co., Ltd. |
| FEI number | 3014164694 |
| Address | Wujiang Economic And Technological Development, 999 Longqiao Road; Songlingzhen Wujiang |
| City | Suzhou |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Jun 24, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data